May 18 | News
LONDON (AP) — GlaxoSmithKline says it will persist with its bid to take over U.S. company Human Genome Sciences despite the target's new 'poison pill' defense.
|
May 17 | News
ROCKVILLE, Md. (AP) — Human Genome Sciences says its board has adopted a "poison pill" shareholder rights plan to ward off unsolicited takeover bids for the biotech drugmaker.
|
May 16 | News
Intuitive Biosciences, Inc. is pleased to announce its agreement to acquire the animal health and research tools assets and businesses of Gentel Biosciences. Intuitive is focused on serological tests for animal health and research and testing tools for the pharmaceutical, CRO, and academic research markets.
|
May 15 | News
Cornerstone Therapeutics and EKR Therapeutics, Inc. today announced that they have entered into a definitive merger agreement whereby Cornerstone Therapeutics will acquire EKR Therapeutics, a privately-held specialty pharmaceutical company focused on the acute-care hospital setting.
|
May 14 | News
Tri-Tronics Co., Inc., a Florida-based manufacturer of photoelectric sensors, fiber-optic light guides and controls, recently announced its acquisition of Photocraft, Inc., a manufacturer of rotary optical encoders.
|
May 9 | News
NEW YORK (AP) — Jazz Pharmaceuticals PLC said Tuesday its net income grew 27 percent in the first quarter after it merged with Azur Pharma.
|
May 7 | News
Walgreen Co. today announced that it has completed its acquisition of certain assets of BioScrip, Inc.'s community specialty pharmacies and centralized specialty and mail service pharmacy businesses.
|
May 3 | News
Novartis announced Wednesday that it signed a definitive agreement to acquire specialty dermatology generic medicine company Fougera Pharmaceuticals in an all-cash deal valued at $1.5 billion.
|
May 1 | News
AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced an antibody discovery partnership with Gilead Sciences, Inc. to develop novel antibody therapeutics.
|
May 1 | News
April proved to be a big month for M&A activity as companies announced more than $29 billion in agreed upon transactions during the month, the bulk of which occurred during the final week.
|